Literatur
- 1
Aletaha D, Eberl G, Nell V P. et al .
Practical progress in realisation of early diagnosis and treatment of patients with
suspected rheumatoid arthritis: results from two matched questionnaires within three
years.
Ann Rheum Dis.
2002;
61
630-634
- 2
Aletaha D, Smolen J S.
The rheumatoid arthritis patient in the clinic: comparing more than 1300 consecutive
DMARD courses.
Rheumatology (Oxford).
2002;
41
1367-1374
- 3
Anderson J J, Felson D T.
Factors predicting response to treatment in rheumatoid arthritis: the importance of
disease duration.
Arthritis Rheum.
2000;
343
1586-1593
- 4
Arnett F C, Edwory S M, Block D A. et al .
The Amercian Rheumatism Association 1987 revised criteria for the classification of
rheumatoid arthritis.
Arthritis Rheum.
1988;
31
315-324
- 5
Backhaus M, Burmester G R, Gerber T, Grassi W, Machold K P, Swen W A, Wakefield R J,
Manger B.
Working Group for Musculoskeletal Ultrasound in the EULAR Standing Committee on International
Clinical Studies including Therapeutic Trials. Guidelines for musculoskeletal ultrasound
in rheumatology.
Ann Rheum Dis.
2001;
60
641-149
- 6
Backhaus M, Burmester G R, Sandrock D, Loreck D, Hess D, Scholz A, Blind S, Hamm B,
Bollow M.
Prospective two year follow up study comparing novel and conventional imaging procedures
in patients with arthritic finger joints.
Ann Rheum Dis.
2002;
61
895-904
- 7
Backhaus M, Kamradt T, Sandrock D, Loreck D, Fritz J, Wolf K J, Raber H, Hamm B, Burmester G R,
Bollow M.
Arthritis of the finger joints: a comprehensive approach comparing conventional radiography,
scintigraphy, ultrasound, and contrast-enhanced magnetic resonance imaging.
Arthritis Rheum.
1999;
42
1232-1245
- 8
Boers M, Verhoeven A C, Markusse H M. et al .
Randomised comparison of combined stop-down prednisolone, methotrexate and sulphasalazine
with sulphasalazine alone in early rheumatoid arthritis: a randomised trial.
Lancet.
1997;
350
309-318
- 9
Breedveld F C, Emery P, Keystone. et al .
Infliximab in active early rheumatoid arthritis.
Ann Rheum Dis.
2004;
63
149-155
- 10
Breedveld F C, Kavanaugh A F, Cohen S B. et al .
Early treatment of rheumatoid arthritis with Adalimumab plus methotrexate vs Adalimumab
alone or methotrexate alone: The PREMIER study.
Arthritis Rheum.
50
(suppl))
L5/520
- 11
Bukhari M, Lunt M, Harrison B J. et al .
Rheumatoid factor is the major predictor of increasing severity of radiographic erosions
in rheumatoid arthritis: results from Norfolk Arthritis Register Study, a large inception
cohort.
Arthritis Rheum.
2002;
46
906-912
- 12
Bukhari M, Lunt M, Harrison B J, Scott D GI. et al .
Rheumatoid factor is the major predictor of increasing severity of radiograph erosions
in rheumatoid arthritis. Results from the Norfolk Arthritis Register Study, a large
inception cohort.
Arthritis Rheum.
2002;
46
906-912
- 13
Capell H AMR, Hunter J A, Porter D. et al .
Lack of radiological and clinical benefit over two years of low dose prednisolone
for rheumatoid arthritis; results of a randomised controlled trial.
Ann Rheum Dis.
2004;
63
797-803
- 14
Combe B, Dougados M, Goupille P. et al .
Prognostic factors for radiographic damage in early rheumatoid arthritis. A multiparameter
prospective study.
Arthritis Rheum.
2001;
44
1736-1743
- 15
De Vries-Bouwstra J K, Goekoop-Ruiterman Y PM, Van Zeben D. et al .
A comparison of clinical and radiological outcomes of four treatment strategies for
early rheumatoid arthritis: results of the Best trial.
Ann Rheum Dis.
2004;
63
(suppl I))
58
- 16
Devauchelle Pensec V, Saraux A, Berthelot J M. et al .
Ability of foot radiographs to predict rheumatoid arthritis in patients with early
arthritis.
J Rheumatol.
2004;
31
63-73
- 17
Emery P, Breedveld F C, Dougados M. et al .
Early referral recommendation for newly diagnosed rheumatoid arthritis: evidence based
development of a clincal guide.
Ann Rheum Dis.
2002;
61
290-297
- 18
Emery P, Salmon M.
Early rheumatoid arthritis: time to aim for remission?.
Ann Rheum Dis.
1995;
54
944-947
- 19
Genovese M C, Bathon J M, Martin R W. et al .
Etanercept versus methotrexate in patients with early rheumatoid arthritis. Two-year
radiographic and clinical outcomes.
Arthritis Rheum.
2002;
46
1433-1450
- 20
Gorman J D, Lum R F, Chen J J. et al .
Impact of shared epitope genotype and ethnicity on erosive disease. A meta-analysis
of 3,240 rheumatoid arthritis patients.
Arthritis Rheum.
2004;
50
400-412
- 21
Goronzy J J, Matteson E L, Fulbright J W. et al .
Prognostic markers of radiographic progression in early rheumatoid arthritis.
Arthritis Rheum.
2004;
50
43-54
- 22
Green M, Marzo-Ortega H, McGonagle D,. et al .
Persistence of mild, early inflammatory arthritis: the importance of disease duration,
rheumatoid factor, and the shared epitope.
Arthritis Rheum.
1999;
42
2184-2188
- 23
Harrison B J, Symmons D P, Barret E M, Silman A S.
The performance of the 1987 ARA classification criteria for rheumatoid arthritis in
a population based cohort of patients with early inflammatory polyarthritis.
J Rheumatol.
1998;
25
2330
- 24
Harrison B J, Symmons D P, Brennan P. et al .
Natural remission in inflammatory polyarthritis: issues of definition and prediction.
Br J Rheumatol.
1996;
35
1096-1100
- 25
Hazes J M, Hayton R, Silman A J.
A reevaluation of the symptom of morning stiffness.
J Rheumatol.
1993;
20
1138-2188
- 26 Kommission Pharmakotherapie der Deutschen Gesellschaft für Rheumatologie zur Therapie
mit Tumornekrosefaktor-hemmenden Substanzen. www.dgrh.de
- 27
Landewe R B, Boers M, Verhoeven A C. et al .
COBRA combination therapy in patients with early rheumatoid arthritis: long-term structural
benefits of a brief intervention.
Arthritis Rheum.
2002;
46
347-356
- 28
Landewe R BM.
Treatment in early inflammatorx arthritis: the SAVE initiative and the DINORA initiative.
Ann Rheum Dis.
2004;
63
48
(suppl I)
- 29
Machold K P, Stamm T A, Eberl G JM. et al .
Very recent onset arthritis-clinical, laboratory findings during the first year of
disease.
J Rheumatol.
2002;
29
2278-2287
- 30
McQueen F M, Benton N, Perry D. et al .
Bone edema scored on magnetic resonance imaging scans of the dominant carpus at presentation
predicts radiographic joint damage of the hands and feet six years later in patients
with rheumatoid arthritis.
Arthritis Rheum.
2003;
48
1718-1827
- 31
Molenaar E T, Voskuyl A E, Dinant H J. et al .
Progression of radiologic damage in patients with rheumatoid arthritis in clinical
remission.
Arthritis Rheum.
2004;
50
36-42
- 32
Möttönen T, Hannonen P, Leirisalo-Repo M. et al .
Comparison of combination therapy with single-drug therapy in early rheumatoid arthritis:
a randomised trial.
Lancet.
1999;
353
1568-1573
- 33
Möttönen T, Paimela L, Leirisalo-Repo M. et al .
Only high disease activity and positive rheumatoid factor indicate poor prognosis
in patients with early rheumatoid arthritis treated with „sawtooth” strategy.
Ann rheum Dis.
1998;
57
533-539
- 34
Müller-Ladner U, Rüther W, Burmester G R.
Diagnostik und Therapie der Rheumatoiden Arthritis.
Dtsch Med Wochenschr.
2004;
129
1318-1321
- 35
Nell V, Machold K P, Eberl G. et al .
Benefit of very early referral and very early therapy with disease modifying anti-rheumatic
drugs in patients with early rheumatoid arthritis.
Rheumatology (Oxford).
2004;
43
906-917
- 36
Nielen M MJ, van Schaardenburg D, Reesink H W. et al .
Specific autoantibodies precede the symptoms of rheumatoid arthritis.
Arthritis Rheum.
2004;
50
380-386
- 37
Ostergaard M, Szkudlarek M.
Imaging in rheumatoid arthritis-why MRI and ultrasonography can no longer be ignored.
Scand J Rheumatol.
2003;
32
63-73
- 38
Plant M J, Jones P W, Saklatvala J. et al .
Patterns of radiology progression in rheumatoid arthritis: results of an 8 year prospective
study.
J Rheumatol.
1998;
25
417-426
- 39
Quinn M A, Green M J, Marzo-Ortega H. et al .
Prognostic factors in a large cohort of patients with early undifferentiated inflammatory
arthritis after application of a structured management protocol.
Arthritis Rheum.
2003;
48
3039-3045
- 40
Raza K, Falciani F, Curnow S J, Ross E J, Lee C Y, Akbar A N, Lord J M, Gordon C,
Buckley C D, Salmon M.
Early rheumatoid arthritis is characterized by a distinct and transient synovial fluid
cytokine profile of T cell and stromal cell origin.
Arthritis Res Ther.
2005;
7
R784-795
- 41
Schellekens G A, deJong B AW, van den Hoogen F H. et al .
Citrulline is an essential constituent of antigenic determinants recognized by rheumatoid
arthritis-specific autoantibodies.
J Clin Invest.
1998;
101
273-281
- 42
Schellekens G A, Visser H, de Jong B AW. et al .
The diagnostic properties of rheumatoid arthritis antibodies recognized a cyclic citrullinated
peptide.
Arthritis Rheum.
2000;
43
155-163
- 43
Schnabel A, Gross W L.
Evidenzbasierte Behandlung der Methotrexat-resistenten Rheumatoiden Arthritis.
Dtsch Med Wochenschr.
2003;
128
147-149
- 44
Schnabel A, Gross W L.
Evidenzbasierte Behandlung der Methotrexat-resistenten Rheumatoiden Arthritis. Zytokinantagonisten.
Dtsch Med Wochenschr.
2003;
128
201-203
- 45 Schneider M, Lelgemann M, Abholz H H, Caratti R, Flügge C, Jäniche H, Kunz R, Krüger K,
Rehart S, Specker C. Management der frühen rheumatoiden Arthritis. Steinkopff-Verlag
Darmstadt ISBN 3 - 7985 - 1497 - 6 2005
- 46
Scott D L, Smith C, Kingsley G.
Joint damage and disability in rheumatoid arthritis: an updated systematic review.
Clin Exp Rheumatol.
2003;
21
S20-S27
(suppl 31)
- 47
Smolen J S, Aletaha D, Machold K P.
Therapeutic strategies in early rheumatoid arthritis.
Best Pract Res Clin Rheumatol.
2005;
19
163-177
- 48
St Clair E W, van der Heijde D M, Smolen J S, Maini R N, Bathon J M, Emery P, Keystone E,
Schiff M, Kalden J R, Wang B, Dewoody K, Weiss R, Baker D. Active-Controlled Study
of Patients Receiving Infliximab for the Treatment of Rheumatoid Arthritis of Early
Onset Study Group .
Combination of infliximab and methotrexate therapy for early rheumatoid arthritis:
a randomized, controlled trial.
Arthritis Rheum.
2004;
50
3432-3443
- 49
Strand V, Simon L S.
Low dose glucocorticoids in early rheumatoid arthritis.
Clin Exp Rheumatol.
2003;
21
S186-S190
(suppl 31)
- 50
Symmons D PM, Hazes J MW, Silman A J.
Cases of early inflammatory polyarthritis should not be classified as having rheumatoid
arthritis.
J Rheumatol.
2003;
30
902-904
- 51
Tarner I H, Härle P, Müller-Ladner U, Gay R E, Gay S.
The different stages of synovitis: acute vs chronic, early vs late and non-erosive
vs erosive.
Best Pract Res Clin Rheumatol.
2005;
19
19-35
- 52
Tunn E J, Bacon P A.
Differentiating persistent from self-limiting symmetrical synovitis in an early arthritis
clinic.
Br J Rheumatol.
1993;
32
97-103
- 53
van Aken J, Lard L R, leCessie S. et al .
Radiological outcome after four years of early versus delayed treatment strategy in
patients with recent onset rheumatoid arthritis.
Ann Rheum Dis.
2004;
63
274-279
- 54
Van der Heijde D M.
Joint erosions in patients with early rheumatoid arthritis.
Br J Rheumatol.
1995;
34
74-78
(suppl 2)
- 55
Visser H, le Cessie S, Vos K. et al .
How to diagnose rheumatoid arthritis early: A prediction model for persistent (erosive)
arthritis.
Arthritis Rheum.
2002;
46
357-365
- 56
Wakefield R J, Green M J, Marzo-Ortega H. et al .
Should oligoarthritis be reclassified? Ultrasound reveals a high prevalence of subclinical
disease.
Ann Rheum Dis.
2004;
63
382-385
- 57
Wolfe F, Cathey M A, Roberts F K.
The latex test revisited rheumatoid factor testing in 8287 rheumatic disease patients.
Arthritis Rheum.
1991;
34
951-960
- 58
Wolfe F, Ross K, Hawley D J. et al .
The prognosis of rheumatoid arthritis and undifferentiated polyarthritis syndrome
in the clinic: a study of 1141 patients.
J Rheumatol.
1993;
20
2005-2009
Dr. med. Jacqueline Detert
Klinik für Rheumatologie und klinische Immunologie, Charité Campus Mitte
Schumannstraße 20/21
10117 Berlin
Phone: 030/450513025
Fax: 030/450513986
Email: jacqueline.detert@charite.de
